David Pyott opened 2006 with a flourish. Allergan Inc., the Irvine-based drug maker he’s run for the past eight years, prevailed with a trumping $3.2 billion bid for Inamed Corp., a coveted maker of ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Last week, vocal investors called for Allergan CEO and Chairman Brent Saunders to give up one of those titles, making room for an outsider at the top. But sources said the outsider some shareholders ...
Allergan CEO David Pyott views the current economic environment as an opportunity to slim down and emerge "leaner and fitter than we’ve ever been before." Doing so, he maintains, will widen the gulf ...
A handful of large Allergan shareholders are privately discussing bringing back the former Allergan chief executive David Pyott in a chairman role, according to people familiar with the matter. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
SOUTH SAN FRANCISCO, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel ...
Fending off a hostile bid last year from partners Valeant ($VRX) and activist investor Bill Ackman wasn't just a lot of work, according to Allergan ($AGN) CEO David ...
David Pyott, the youthful-looking chief executive of Irvine drug maker Allergan Inc., has a secret that’s out of the bag. Pyott said in an interview with the Financial Times he’s used Allergan’s ...
NEW YORK, June 20, 2019 /PRNewswire/ -- The David and Molly Pyott Foundation will invest USD $2 million over a period of 3 years (2019- 2021) to further support Orbis's work in Zambia to strengthen ...
IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced the appointment of David E. I. Pyott, a distinguished leader in the global ...
SOUTH SAN FRANCISCO, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results